David R Berk MD
Pediatric Dermatology
Director, Clinical Development - Dermatology, Allergan, Inc, Irvine, CA; Teledermatologist (volunteer/unpaid), Direct Dermatology, Bay Area, CA
Join to View Full Profile
4921 Parkview PlSuite 5BSaint Louis, MO 63110
Phone+1 314-362-2643
Fax+1 314-747-8693
Dr. Berk is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Pediatric Dermatology, 2008 - 2009
Washington University/B-JH/SLCH ConsortiumResidency, Dermatology, 2005 - 2008- Stanford Health Care-Sponsored Stanford UniversityInternship, Internal Medicine, 2004 - 2005
Stanford University School of MedicineClass of 2004
Certifications & Licensure
MO State Medical License 2009 - 2026
CA State Medical License 2008 - 2025
American Board of Dermatology Dermatology- American Board of Dermatology Pediatric Dermatology
Awards, Honors, & Recognition
- Fellow (FAAD) American Academy of Dermatology
Clinical Trials
- Pharmacokinetics (PK), Safety, Efficacy and Maximal Use PK of ARQ-151 in Adolescents/Children With Mild/Moderate Eczema Start of enrollment: 2019 Dec 23
Publications & Presentations
PubMed
- 7 citationsThe Proposed PASI-HD Provides More Precise Assessment of Plaque Psoriasis Severity in Anatomical Regions with a Low Area ScoreKim A. Papp, Mark Lebwohl, Leon H Kircik, David M. Pariser, Bruce Strober
Dermatology and Therapy. 2021-07-08 - 7 citationsBiallelic variants in RNU12 cause CDAGS syndromeChao Xing, Mohammed Kanchwala, Jonathan J. Rios, Tommy Hyatt, Richard C. Wang
Human Mutation. 2021-06-03 - 15 citationsRoflumilast Cream Improves Signs and Symptoms of Plaque Psoriasis: Results from a Phase 1/2a Randomized, Controlled Study.Kim A. Papp, Melinda Gooderham, Michael Droege, Charlotte Merritt, David W Osborne
Journal of Drugs in Dermatology. 2020-08-01
Press Mentions
Common Features of Periocular TineaMarch 14th, 2011
Topical Oxymetazoline Hydrochloride 1.0% Effectively Reduces Persistent Facial Erythema of Rosacea on Day 1August 2nd, 2018
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
